GE HealthCare Technologies Inc. (GEHC)
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
GEHC Stock May Rise With $138M Investment in Cork Facility Expansion
GE HealthCare invests $138M to expand its Cork facility to enhance manufacturing capacity for life-saving imaging contrast media and strengthen its global supply chain.
GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series
GE HealthCare launches the enhanced Voluson Expert Series to advance women's health with faster, more precise imaging for improved care in obstetrics and gynecology.
GE HealthCare Technologies: Still A Solid Long-Term Play
GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth, outperforming the S&P 500 by a wide margin. Despite mixed financial performance, the company remains undervalued compared to competitors, with potential for further growth in a large, expanding market. Management's optimistic guidance for 2024 and beyond, coupled with strategic investments and partnerships, supports continued revenue and profit growth.
GEHC Stock Gains on the Collaborated Launch of Care Innovation Hub
GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California, San Francisco.
Reasons to Add GE HealthCare Stock to Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
GE HealthCare announces a seven-year strategic collaboration with Sutter Health.
GEHC or PODD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stock Of The Day: Where Will The GE HealthCare Rally End?
GE HealthCare Technologies Inc. GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.
GEHC vs. PODD: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?
